drugset / Trial / NCT01626820
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study is designed to test the immunogenicity in terms of Hemagglutination Inhibition (HI) antibodies against each of the three vaccine influenza strains and reactogenicity and safety of Fluviral® containing the influenza strains recommended for the 2012-2013 season.
Timeline
- Start
- 2012-07-19
- Primary completion
- 2012-08-10
- Completion
- 2012-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluviral | Vaccine | — | Intramuscular |